Our Services
Medical Information
Helpful Resources
Published on: 4/13/2026
Myasthenia gravis is an autoimmune disorder that disrupts nerve-to-muscle signaling by attacking acetylcholine receptors, often linked to thymus abnormalities. Common symptoms include muscle weakness that worsens with activity and improves with rest, such as drooping eyelids, double vision, difficulty chewing or swallowing, and in serious cases, trouble breathing.
Next steps depend on severity: seek urgent care immediately for breathing or swallowing problems. Otherwise, consult a neurologist for antibody testing, EMG, and chest imaging. Treatment options include pyridostigmine, immunosuppressants, thymectomy, and IVIG or plasma exchange.
Because myasthenia gravis symptoms overlap with many other conditions—and early recognition can prevent dangerous complications—it's worth clarifying what may be driving your symptoms before your next medical visit. Take a free, instant, online symptom check to better understand what's going on and confidently navigate your next steps.
Reviewed for medical accuracy: 07/09/2026
If you've noticed muscles that seem to "give out" without warning—drooping eyelids, double vision, trouble chewing, or weakness that worsens as the day goes on—you may be wondering what's happening. One possible cause is myasthenia gravis, a chronic autoimmune condition that affects how nerves communicate with muscles.
While the symptoms can be unsettling, many people with myasthenia gravis live full, active lives with proper diagnosis and treatment. Here's what you need to know about why myasthenia gravis occurs and what medically approved next steps look like.
Myasthenia gravis is a long-term autoimmune disorder that causes muscle weakness. It happens when your immune system mistakenly attacks the connection between nerves and muscles.
Under normal conditions:
In myasthenia gravis:
The key feature of myasthenia gravis is muscle weakness that worsens with activity and improves with rest.
The exact cause isn't always clear, but we know several medically established factors are involved.
Myasthenia gravis is an autoimmune condition. The body produces antibodies against:
These antibodies interfere with normal muscle contraction.
The thymus gland (located behind the breastbone) plays a role in immune system development. In many people with myasthenia gravis:
Myasthenia gravis is not usually inherited, but genetic susceptibility may play a role. Certain infections or immune triggers may contribute, though this is still being studied.
Symptoms vary widely. Some people have mild eye involvement only, while others experience more widespread weakness.
In severe cases, breathing muscles can weaken. This is called a myasthenic crisis and requires emergency medical care.
Myasthenia gravis ranges from mild to severe. While many cases are manageable, certain symptoms require immediate attention:
If any of these occur, seek emergency medical care immediately.
Even outside of emergencies, persistent or unexplained muscle weakness should be evaluated by a doctor.
A healthcare provider—often a neurologist—uses several tools to confirm a diagnosis.
Doctors look for:
These tests evaluate nerve-muscle communication.
Early and accurate diagnosis helps prevent complications and improves long-term outcomes.
If you're experiencing unexplained muscle weakness or fatigue that worsens throughout the day, taking Ubie's free AI-powered symptom checker can help you identify what might be causing your symptoms and guide you on whether you should see a doctor right away.
There is no cure for myasthenia gravis, but treatments are highly effective for most people. Management focuses on improving muscle strength and reducing immune attack.
Acetylcholinesterase inhibitors (such as pyridostigmine):
These medications help control symptoms but do not treat the underlying immune cause.
These treatments reduce abnormal immune activity:
They may take weeks to months to reach full effect.
Recommended in:
Studies show thymectomy can:
Used in myasthenic crisis or severe worsening:
These provide short-term relief by removing or neutralizing harmful antibodies.
Medical treatment is the foundation, but daily habits matter too.
Helpful strategies include:
Always speak to your doctor before starting new medications or supplements.
The prognosis for myasthenia gravis has improved dramatically over the past several decades.
However, untreated or poorly managed disease can lead to serious complications, including breathing failure. That's why early diagnosis and ongoing medical care are essential.
You should consult a healthcare provider if you experience:
Seek immediate medical care if you develop:
These could indicate a medical emergency.
Even if symptoms feel mild, it's important to speak to a doctor about anything that could be serious or life-threatening.
Myasthenia gravis can feel confusing at first—especially because symptoms often fluctuate. But it is a well-recognized autoimmune condition with established, effective treatments.
If you're noticing unusual muscle fatigue or weakness, don't ignore it. Early evaluation leads to better outcomes. Taking a few minutes to check your symptoms with a free online symptom checker can help you understand what might be happening and give you the confidence to reach out to a healthcare provider.
Most importantly, speak to a doctor if you suspect myasthenia gravis or experience worsening symptoms. With proper care, many people manage this condition successfully and maintain a strong quality of life.
(References)
* Gilhus NE. Myasthenia Gravis. N Engl J Med. 2023 Mar 9;388(10):926-939. doi: 10.1056/NEJMra2208064. PMID: 36884323.
* Dresser L, Wlodarski R, Saluk-Bijak J, Bijak M. Pathogenesis of Myasthenia Gravis. J Clin Med. 2020 Nov 6;9(11):3541. doi: 10.3390/jcm9113541. PMID: 33193489; PMCID: PMC7694901.
* Narayanaswami P, Sanders DB, Guidon AC, Benatar M, Bird SJ, Bourke E, Brannagan TH 3rd, Clifford R, Ciafaloni E, Cohen ML, Dimberg EL, Donofrio P, Evoli A, Harms M, Hynan LS, Karam C, Kuntz N, Levine T, Maselli RA, Meriggioli MN, Mongiovi P, Pasnoor P, Richman DP, Rivner MH, Sachdev A, Silvestri NJ, Sivak M, Tandan R, Tossberg JT, Verma A, Vitols S, Walk D, Witcher M, Wolfe G, Zinman L, Partners in MG. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology. 2021 Aug 17;97(7):350-362. doi: 10.1212/WNL.0000000000012290. PMID: 34261778; PMCID: PMC8372439.
* Silvestri NJ. Emerging Therapies in Myasthenia Gravis. Neurol Clin. 2022 Aug;40(3):497-512. doi: 10.1016/j.ncl.2022.04.004. PMID: 35921614.
* Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz NL, Massey JM, Melms A, Murai H, Nicolle MW, Palace J, Richman DP, Sussman J. Myasthenia gravis: updated clinical insights and treatment strategies. Lancet Neurol. 2021 Nov;20(11):957-973. doi: 10.1016/S1474-4422(21)00302-8. Epub 2021 Oct 22. PMID: 34687834.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.